Pharmacy Scholarship: Zac Cox

Cox ZL, Lai P, Lewis CM, Lindenfeld J. Body mass index and all-cause readmissions following acute heart failure hospitalization. Int J Obes. 2019:10.1038/s41366-41019-40518-41366. doi: 10.1038/s41366-019-0518-6

Cox ZL, Lai P, Lewis CM, Lindenfeld J. Change in admission blood glucose from chronic glycemic status in acute heart failure hospitalization and 30-day outcomes: A retrospective analysis. Int J Cardiol. 2019. 10.1016/j.ijcard.2019.07.069

Cox ZL, Hung R, Lenihan DJ, Testani JM. Diuretic strategies for loop diuretic resistance in acute heart failure: The 3T trial. JACC Heart Fail. 2019:S2213-1779(2219)30804-30802. doi: 10.1016/j.jchf.2019.09.012

Xiong L, Chinaeke EE, Lu K, Lenihan DJ, Merritt TE, Cox ZL. Evaluation of severe myalgia induced by continuous-infusion bumetanide in patients with acute heart failure. Pharmacotherapy. 2019.

Charokopos A, Griffin M, Rao VS, Inker, L, Sury K, Asher J, Turner J, Mahoney D, Cox ZL, Wilson FP, Testani J. M. Serum and urine albumin and response to loop diuretics in heart failure. Clin J Am Soc Nephrol. 2019;14(5):712-718.

Cox ZL, Lai P, Lewis CM, Lindenfeld J, Collins SP, Lenihan DJ. Customizing national models for a medical center's population to rapidly identify patients at high risk of 30-day all-cause hospital readmission following a heart failure hospitalization. Heart Lung. 2018;47(4):290-296.

Sabato LA, Johnson DC, Haglund N, Keebler M, Cox ZL. Pharmacokinetics of sildenafil in patients with a left ventricular assist device: A word of caution. ASAIO J. 2018.

Cox ZL, Lai P, Lewis CM, Lenihan DJ. Centers for Medicare and Medicaid services' readmission reports inaccurately describe an institution's decompensated heart failure admissions. Clin Cardiol. 2017;40(9):620-625.

Tunney RK, Jr., Johnson DC, Wang L, Cox ZL. Impact of pharmacist intervention to increase compliance with guideline-directed statin therapy during an acute coronary syndrome hospitalization. Ann Pharmacother. 2017;51(5):394-400.

Sabato LA, Mendes LA, Cox ZL. Restrictive cardiomyopathy associated with long-term use of hydroxychloroquine for systemic lupus erythematosus. J Pharm Pract. 2017;30(5):571-575.

Cox ZL, Lewis CM, Lai P, Lenihan DJ. Validation of an automated electronic algorithm and "dashboard" to identify and characterize decompensated heart failure admissions across a medical center. Am Heart J. 2017;183:40-48.

Haglund NA, Burdorf A, Jones T, Shostrom V, Um J, Ryan T, Shillcutt S, Fischer P, Cox ZL, Raichlin E, Anderson DR, Lowes BD, Dumitru I. Inhaled milrinone after left ventricular assist device implantation. J Card Fail. 2015;21(10):792-797.

Haglund NA, Cox ZL, Lee JT, Song Y, Keebler ME, DiSalvo TG, Maltais S, Lenihan DJ, Wigger MA. Are peripherally inserted central catheters associated with increased risk of adverse events in status 1B patients awaiting transplantation on continuous intravenous milrinone? J Card Fail. 2014;20(9):630-637. doi: 10.1016/j.cardfail.2014.06.004

Powers JS, Cox ZL, Young J, Howell M, DiSalvo T. Critical pathways: Implementation of the Coleman Care Transitions Program in individuals hospitalized with congestive heart failure. J Am Geriatr Soc. 2014;62(12):2442-2444. 10.1111/jgs.13174

Cox ZL, Lenihan DJ. Loop diuretic resistance in heart failure: Resistance etiology-based strategies to restoring diuretic efficacy. J Card Fail. 2014;20(8):611-622.

Cox ZL, McCoy AB, Matheny ME, Bhave G, Peterson NB, Siew ED, Lewis J, Danciu I, Bian A, Shintani A, Ikizler TA, Neal EB, Peterson JF. Adverse drug events during AKI and its recovery. Clin J Am Soc Nephrol. 2013;8(7):1070-1078.

Cox ZL, Calcutt MW, Morrison TB, Akers WS, Davis MB, Lenihan DJ. Elevation of plasma milrinone concentrations in stage D heart failure associated with renal dysfunction. J Cardiovasc Pharmacol Ther. 2013;18(5):433-438. doi: 10.1177/1074248413489773

McCoy AB, Cox ZL, Neal EB, Waitman LR, Peterson NB, Bhave G, Siew ED, Danciu I, Lewis JB, Peterson JF. Real-time pharmacy surveillance and clinical decision support to reduce adverse drug events in acute kidney injury: A randomized, controlled trial. Appl Clin Inform. 2012;3(2):221-238.

Cox ZL, Nelsen CL, Waitman LR, McCoy JA, Peterson JF. Effects of clinical decision support on initial dosing and monitoring of tobramycin and amikacin. Am J Health Syst Pharm. 2011;68(7):624-632.

Wilson NS, Hudson JQ, Cox ZL, King T, Finch CK. Hyperkalemia-induced paralysis. Pharmacotherapy. 2009;29(10):1270-1272. 10.1592/phco.29.10.1270